What is the appropriate treatment for functional constipation in a 4‑year‑old girl?

Treatment for Constipation in a 4-Year-Old Girl

For a 4-year-old with functional constipation, start with polyethylene glycol (PEG) as first-line pharmacological therapy after initial education and disimpaction if needed, with doses ranging from 0.25 to 1.5 g/kg daily. 1, 2, 3, 4

Initial Management Approach

Education and Assessment

Begin by explaining to the family that functional constipation is a common, treatable condition affecting 5-30% of children. Rule out red flags through history and physical examination:

• Look for delayed passage of meconium (suggests Hirschsprung disease)
• Check for abnormal neurological exam or absent anal wink reflex
• Assess for failure to thrive or developmental delays
• Examine for anal fissures or abnormal anal position

No laboratory or radiological investigations are needed for functional constipation unless red flags are present. 2, 4

Three-Step Treatment Protocol

Step 1: Disimpaction (if fecal impaction present)

• Oral PEG 3350 is the preferred method over rectal interventions 3
• Use higher doses initially: 1-1.5 g/kg daily for 3-6 days
• Rectal interventions (enemas, suppositories) carry risk of mechanical trauma and should be avoided for routine use 3

Step 2: Maintenance Therapy Start immediately after disimpaction is complete:

Pharmacological (First-Line):

• PEG 3350 with or without electrolytes: 0.25-1.5 g/kg daily 5, 1, 3, 4
  • This is safe, effective, and well-tolerated in children of all ages
  • Has moderate-quality evidence supporting its use
  • Response is durable over 6 months
  • Side effects: abdominal distension, loose stools, flatulence, nausea

Alternative if PEG unavailable or not tolerated:

• Lactulose can be used, though evidence is more limited 4

Dietary Modifications:

• Increase fluid intake throughout the day
• Encourage fruits with sorbitol content (prunes, pears, apples) 6
• Adequate dietary fiber, though fiber supplements alone have limited evidence in children and may worsen bloating 5

Behavioral Interventions:

• Establish regular toilet sitting times, particularly after meals
• Encourage proper positioning: feet supported, knees above hips
• Avoid punishment or pressure around bowel movements
• Positive reinforcement for toilet sitting attempts

Step 3: Follow-Up and Adjustment

• Goal: Daily soft, painless bowel movements without straining
• Continue maintenance therapy for several months minimum
• Gradually taper laxatives only after sustained symptom resolution (typically 3-6 months)
• Early discontinuation leads to relapse in most cases

Common Pitfalls to Avoid

1. Premature discontinuation of laxatives: Maintenance therapy must continue for months, not weeks. Many families stop treatment too early when symptoms improve, leading to recurrence.

2. Inadequate dosing: Don't hesitate to use the full dose range of PEG (up to 1.5 g/kg). Underdosing is a common cause of treatment failure.

3. Focusing only on medication: Without behavioral toilet training and dietary counseling, pharmacological therapy alone often fails.

4. Using stimulant laxatives as first-line: While senna and bisacodyl have a role, osmotic laxatives like PEG are preferred for maintenance in children 5.

5. Expecting immediate results: Explain to families that treatment may take weeks to months for full effect.

Treatment-Resistant Cases

If symptoms persist after 3-6 months of appropriate PEG therapy at adequate doses:

• Reassess for organic causes or anatomical abnormalities
• Consider referral to pediatric gastroenterology
• Evaluate for defecatory disorders requiring pelvic floor therapy 7
• Consider adjunctive therapies like abdominal massage (shown to reduce symptoms when added to standard therapy) 8

For children 6 years and older with treatment-resistant constipation, linaclotide is now FDA-approved as the first pharmacological agent specifically for pediatric functional constipation 1, 9, though this patient is currently too young for this option.

The evidence strongly supports PEG as the cornerstone of treatment, with behavioral and dietary modifications as essential adjuncts rather than standalone therapies 5, 1, 2, 3, 4.